| Dr Kelsey Thompson Martin, MD | |
|
240 Indian River Rd Ste A1, Orange, CT 06477-3690 | |
| (203) 795-1664 | |
| Not Available |
| Full Name | Dr Kelsey Thompson Martin |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 14 Years |
| Location | 240 Indian River Rd Ste A1, Orange, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467763946 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 270677 (New York) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 62011 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
A preventive treatment for dementia may proceed to clinical trials after successful animal testing.
While the Japanese market still dominates deal activities in the Asia-Pacific (APAC) region, companies and research institutes in emerging APAC countries have recently been attracting high calibre collaborators, according to the latest analysis by Datamonitor.
Allergan, plc. today announced that the company has received approval from the U.S. Food and Drug Administration to market 28 additional styles of Natrelle 410 silicone-filled breast implants, giving surgeons and patients more options to achieve desired outcomes.
VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute-supported clinical trials that demonstrated that trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients.
Rush University Medical Center neurosurgeon Dr. Roy A. E. Bakay and colleagues from Emory University, Atlanta found the therapy Spheramine was well-tolerated and patients experienced improvement in Parkinsonian symptoms (tremor, rigidity, slowness of movements, and impaired balance and coordination.)
› Verified 3 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
A preventive treatment for dementia may proceed to clinical trials after successful animal testing.
While the Japanese market still dominates deal activities in the Asia-Pacific (APAC) region, companies and research institutes in emerging APAC countries have recently been attracting high calibre collaborators, according to the latest analysis by Datamonitor.
Allergan, plc. today announced that the company has received approval from the U.S. Food and Drug Administration to market 28 additional styles of Natrelle 410 silicone-filled breast implants, giving surgeons and patients more options to achieve desired outcomes.
VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute-supported clinical trials that demonstrated that trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients.
Rush University Medical Center neurosurgeon Dr. Roy A. E. Bakay and colleagues from Emory University, Atlanta found the therapy Spheramine was well-tolerated and patients experienced improvement in Parkinsonian symptoms (tremor, rigidity, slowness of movements, and impaired balance and coordination.)
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kelsey Thompson Martin, MD 240 Indian River Rd Ste A1, Orange, CT 06477-3690 Ph: (203) 795-1665 | Dr Kelsey Thompson Martin, MD 240 Indian River Rd Ste A1, Orange, CT 06477-3690 Ph: (203) 795-1664 |
News Archive
A preventive treatment for dementia may proceed to clinical trials after successful animal testing.
While the Japanese market still dominates deal activities in the Asia-Pacific (APAC) region, companies and research institutes in emerging APAC countries have recently been attracting high calibre collaborators, according to the latest analysis by Datamonitor.
Allergan, plc. today announced that the company has received approval from the U.S. Food and Drug Administration to market 28 additional styles of Natrelle 410 silicone-filled breast implants, giving surgeons and patients more options to achieve desired outcomes.
VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute-supported clinical trials that demonstrated that trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients.
Rush University Medical Center neurosurgeon Dr. Roy A. E. Bakay and colleagues from Emory University, Atlanta found the therapy Spheramine was well-tolerated and patients experienced improvement in Parkinsonian symptoms (tremor, rigidity, slowness of movements, and impaired balance and coordination.)
› Verified 3 days ago
Jeffrey Reynolds, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 240 Indian River Rd, Suite A5, Orange, CT 06477 Phone: 203-799-1252 Fax: 203-799-3252 | |
Dr. Peter Yenlung Chuang, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 240 Indian River Rd, Suite A5, Orange, CT 06477 Phone: 203-799-1252 Fax: 203-799-3252 | |
Paul Kevin Clarke, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 339 Boston Post Rd, Suite 210, Orange, CT 06477 Phone: 203-795-5652 | |
Bayode Ademola Afolalu, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 240 Indian River Road, A5, Orange, CT 06477 Phone: 203-799-1252 Fax: 203-799-3252 | |
Dr. Jasdeep Sidana, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 521 Boston Post Road, Orange, CT 06477 Phone: 203-523-0971 Fax: 203-529-3273 | |
Dr. Richard Joseph Sorcinelli, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 791 Orange Center Rd, Orange, CT 06477 Phone: 203-891-0589 |